CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Shandong Ruilang Medicine Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Shandong Ruilang Medicine Co Ltd
Branch B
No.23 Dunhua Road, Shibei District
Phone: +86 53288800531p:+86 53288800531 QINGDAO, SDG  266000  China Fax: +86 53288800531f:+86 53288800531

Business Summary
Shandong Ruilang Medicine Co Ltd is a China-based company mainly engaged in the wholesale and retail chain business of medical supplies. The Company distributes its products through online malls and offline chain retail stores and wholesale models. Its products include medicines, medical machinery, health products, daily necessities and food. It also engages in house rental business.
(Source: ARS)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/201412/31/2014Yes----

General Information
Outstanding Shares: 5,000,000 (As of 12/31/2014)
Fax Number: +86 53288800531


Copyright © 2021 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, May 14, 2021